Aminoglycosides Flashcards

(15 cards)

1
Q

Aminoglycosides Examples?

A

Amikacin
Gentamicin
Neomycin
Streptomycin
Tobramycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Key points about aminoglycosides

A
  • All bacteriocidal and are active against some gram positive and many gram negative organisms
  • Broad spectrum antibiotics
  • TAG- Tobramycin,Amikacin and Gentamicin are active agents against pseudomonas aeruginosa ( which causes pneumonia)
  • Streotomycin is active against mycobacterium tuberculosis (reserved almost entirely for tuberculosis)
  • Not given orally( not absorbed from the gut) therefore must be given by injections for systemic infections
  • Gentamicin is the most common aminoglycoside in the UK
  • Used to treat serious infections (eye,ear,diabetic foot, endocarditis, septicaemia,meningitis and other CNS infections and pneumonia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common side effects of aminogylcosides

A
  • Dose related ( because it has a narrow therapeutic index)
  • Parenteral treatment should not exceed 7 days wherever possible
  • renally excreted so minor or renal function and care with elderly patients
  • signs of Ototoxicity
  • Nephrotoxicity - occurs mostly in patients with renal impairment
  • risk in pregnancy - auditory damage in infants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are Ototoxicity signs

A
  • Tinnitus or ringing in ears
  • Hearing loss
  • Dizziness
  • Uncoordination in movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nephrotoxicity

A
  • decreased urine output
  • SOB
  • Fluid retention( swelling in legs,ankles and feet)
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Important interactions of aminoglycosides

A
  • Ototoxicity with diuretics
  • Nephrotoxicity with cephalosporins, vancomycin or ciclosporin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dose adjustment for aminoglycosides

A
  • if renal impairment - increase dose interval
  • if renal impairment is severe, reduce dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Monitoring requirements

A
  • plasma concentration
  • renal function
  • auditory and vestibular function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Specific monitoring

A
  • serum concentration should be monitored in patients receiving parenteral aminoglycosides
  • Monitored in elderly, obese,cystic fibrosis, renal impairment and higher doses
  • Take blood samples approximately an hour after administration (peak concentration) and also just before next dose(trough)
  • if pre dose is too high (trough) then increase the dosing interval
  • if post dose is too high, decrease the dose, if within range then maintain the dose. If below the range then increase the dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gentamicin - For endocarditis

A

Monitoring:

1) For IM and IV use for multiple daily regimen
Peak concentration should be = 5-10 mg/l
Trough concentration should be = Less than 2 mg/L

2) For multiple daily dose regimen in endocarditis
Peak concentration should be between = 3-5 mg/L
Trough concentration should be less than 1 mg/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amikacin

A

Is more stable to enzyme inactivation than gentamicin and used for gentamicin resistant bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neomycin sulfate

A

Too toxic for parenteral admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tobramycin

A

Administered by nebuliser or inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of gentamicin

A
  • antibiotic associated colitis
  • blood disorders
  • depression
  • neurotoxicity
  • vestibular damage
  • skin reactions
  • tinnitus
  • nausea and vomitting
  • Nephrotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MHRA warning

A
  • aminoglycosides increase the risk of deafness (toxicity) in patients that have mitochondrial mutations
  • potential for histamine related adverse reactions with some batches, caution with patients on drugs which release histamine eg. Opioids w
How well did you know this?
1
Not at all
2
3
4
5
Perfectly